# Daniel Norman, M.D. – FDA Inspection, Oct 17, 2023

Source: https://www.keypedia.com/records/fda_inspections/daniel-norman-md/1192be54-4857-434f-af85-e64593fdb150
Source feed: FDA_Inspections

> FDA inspection 1220488 of Daniel Norman, M.D., October 17, 2023. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 312. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1220488
- Company Name: Daniel Norman, M.D.
- Inspection Date: 2023-10-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1130113 - 2020-09-02
- FDA Inspection 842133 - 2013-08-02

## Related Officers

- [Investigator](https://www.keypedia.com/people/lan-t-tran/ab9c1008-c03f-425f-ac3c-a569d3e5037c)

Company: https://www.keypedia.com/companies/daniel-norman-md/bd34bdd0-4f58-4a86-9a6d-0cfc983e300c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
